Trials / Conditions / Relapsed/Refractory Hematological Malignancies
Relapsed/Refractory Hematological Malignancies
4 registered clinical trials studyying Relapsed/Refractory Hematological Malignancies — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Study of APG-3288 in Relapsed/Refractory Blood Cancers NCT07424833 | Ascentage Pharma Group Inc. | Phase 1 |
| Not Yet Recruiting | A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies NCT07294300 | Qilu Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies NCT05528887 | The Affiliated People's Hospital of Ningbo University | Phase 1 |
| Unknown | A Study of TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies NCT04412577 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 1 |